Do HT Use and Hormone-Receptor Status Affect Recurrence After Treatment for Early-Stage Breast Cancer?
Hormone-receptor–positive tumor status resulted in lower risk for recurrence among women who have used HT.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)